VEGF-B:一个具有新兴治疗应用的多方面的调制器
Chunsik Lee1, Myung-Jin Kim2, Eunyoung Jung2
1Department of R&D, GEMCRO Inc, Seoul, Republic of Korea.
Pharmacological research
|December 12, 2025
概括
血管内皮生长因子B (VEGF-B) 在新陈代谢和免疫中起着复杂的作用,与VEGF-A不同. 了解VEGF-B的理解
科学领域:
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
- 代谢研究研究 代谢研究
背景情况:
- 血管内皮生长因子B (VEGF-B) 越来越多地被认为具有超出血管生成的作用.
- 与VEGF-A不同,VEGF-B通过VEGFR1和NRP1.1.影响组织特异性功能,如脂肪酸运输,神经元生存和免疫代谢.
- VEGF-B表现出取决于背景的作用,矛盾的是抑制或促进癌症的进展和免疫逃避.
研究的目的:
- 审查关于VEGF-B多样化的生物功能的当前知识.
- 为VEGF-B信号网络提出一个机制框架.
- 概述开发针对VEGF-B的精密疗法在各种疾病中的策略.
主要方法:
- 关于VEGF-B研究中最近发现的文献综述.
- 对VEGF-B的受体相互作用的分析 (VEGFR1,NRP1,FGFR1).
- 整合了关于VEGF-B在T细胞存活和疾病背景中的作用的发现.
主要成果:
- VEGF-B对血管,代谢和免疫系统相互作用至关重要.
- 最近的发现强调了FGFR1作为关键受体和VEGF-B在T细胞存活中的重要性.
- 临床翻译受到不完全理解的阻碍,正如糖尿病病失败的试验所示.
结论:
- VEGF-B是一种关键的调节剂,在健康和疾病中具有矛盾的作用.
- 需要进一步的研究来阐明复杂的信号和治疗潜力.
- 开发精密疗法需要解决翻译挑战,以利用VEGF-B的好处,同时保持平衡.
相关概念视频
Regulation of Angiogenesis and Blood Supply
3.3K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.3K
TGF - β Signaling Pathway
10.4K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.4K
Mechanism of Angiogenesis
6.6K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
6.6K
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
424
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
424
Non-Canonical Wnt Signaling Pathways
8.2K
Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
8.2K
Clinical Applications of Epidermal Stem Cells
3.2K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
3.2K


